Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Proteomic Markers of Brain and Cognitive Outcomes as Early Indicators of Dementia Risk
EF 2025-26
Résumé
As living conditions improve, people worldwide are living longer. As such, late-life conditions such as dementia are becoming an increasingly major challenge for the healthcare system. Developing effective treatments for dementia has been challenging; however, research shows that interventions are most effective when started early, before significant cognitive decline. While some biomarkers of dementia risk, such as phosphorylated tau amyloid in blood plasma and cerebrospinal fluid, have been developed and validated, recent advances in large-scale proteomics could provide a more comprehensive dementia risk profile. Among key early signs of dementia are subtle cognitive impairments and loss of gray matter structure that could serve as a proxy for deteriorating brain and cognitive health. In this project, we will leverage large-scale proteomic datasets (UK Biobank, ADNI) to better understand how levels of plasma proteins predict brain cognitive health in older adults. We will use predictive modelling and machine learning techniques to identify combinations of proteins that can help us predict who may be at an elevated risk of cognitive decline and developing dementia. We will then test these outcomes in a separate dataset that includes participants who have mild cognitive impairment and dementia. In addition, we will explore whether these patterns differ between males and females, and whether they are influenced by lifestyle or environmental factors. Overall, combining multiple types of datasets will allow us to improve early detection of dementia, guide strategies to slow or prevent cognitive decline, and help develop more personalized treatments.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572713
Name
Hu Julianne
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Proteomic Markers of Brain and Cognitive Outcomes as Early Indicators of Dementia Risk
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Aging; Biomarkers; Brain Health; Cognition; Cognitive Impairment; Dementia; Machine Learning; Neurodegeneration; Proteomics; Risk Prediction
Abstract
As living conditions improve, people worldwide are living longer. As such, late-life conditions such as dementia are becoming an increasingly major challenge for the healthcare system. Developing effective treatments for dementia has been challenging; however, research shows that interventions are most effective when started early, before significant cognitive decline. While some biomarkers of dementia risk, such as phosphorylated tau amyloid in blood plasma and cerebrospinal fluid, have been developed and validated, recent advances in large-scale proteomics could provide a more comprehensive dementia risk profile. Among key early signs of dementia are subtle cognitive impairments and loss of gray matter structure that could serve as a proxy for deteriorating brain and cognitive health. In this project, we will leverage large-scale proteomic datasets (UK Biobank, ADNI) to better understand how levels of plasma proteins predict brain cognitive health in older adults. We will use predictive modelling and machine learning techniques to identify combinations of proteins that can help us predict who may be at an elevated risk of cognitive decline and developing dementia. We will then test these outcomes in a separate dataset that includes participants who have mild cognitive impairment and dementia. In addition, we will explore whether these patterns differ between males and females, and whether they are influenced by lifestyle or environmental factors. Overall, combining multiple types of datasets will allow us to improve early detection of dementia, guide strategies to slow or prevent cognitive decline, and help develop more personalized treatments.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hu, Julianne
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~